Abpro Holdings, INC. (ABPWW) — SEC Filings

Latest SEC filings for Abpro Holdings, INC.. Recent 8-K filing on Dec 15, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Abpro Holdings, INC. on SEC EDGAR

Overview

Abpro Holdings, INC. (ABPWW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 15, 2025: Abpro Holdings, Inc. filed an 8-K on December 15, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly Atlantic Coastal Acquisition Corp. II, is incorporated in Delaware and has its principal executive offices in Burlington, MA. This filing does not

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 9 bearish, 38 neutral, 3 mixed. The dominant filing sentiment for Abpro Holdings, INC. is neutral.

Filing Type Overview

Abpro Holdings, INC. (ABPWW) has filed 29 8-K, 3 S-1/A, 4 10-Q, 3 S-1, 1 8-K/A, 6 DEFA14A, 3 DEF 14A, 1 10-K with the SEC between Sep 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

Risk Profile

Risk Assessment: Of ABPWW's 48 recent filings, 11 were flagged as high-risk, 13 as medium-risk, and 24 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Abpro Holdings, INC.'s most recent 10-Q filing (Nov 14, 2025):

Key Executives

Industry Context

Abpro Holdings operates in the biotechnology sector, focusing on developing novel antibody-based therapeutics. This industry is characterized by high research and development costs, long development cycles, and significant regulatory hurdles. The competitive landscape includes numerous established pharmaceutical companies and emerging biotech firms, all vying for market share and investor capital. Trends include a focus on targeted therapies, advancements in antibody engineering, and strategic partnerships to fund clinical trials and commercialization.

Top Tags

Biotechnology (7) · corporate-action (7) · filing (5) · delisting (5) · proxy-statement (5) · sec-filing (4) · 8-k (4) · Reverse Stock Split (4) · financials (4) · listing-standards (4)

Executive Compensation

From the most recent DEF 14A filing (Sep 8, 2025):

Key Numbers

Related Companies

ABP · ABPR · ACAB

Frequently Asked Questions

What are the latest SEC filings for Abpro Holdings, INC. (ABPWW)?

Abpro Holdings, INC. has 50 recent SEC filings from Sep 2024 to Dec 2025, including 29 8-K, 6 DEFA14A, 4 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ABPWW filings?

Across 50 filings, the sentiment breakdown is: 9 bearish, 38 neutral, 3 mixed. The dominant sentiment is neutral.

Where can I find Abpro Holdings, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Abpro Holdings, INC. (ABPWW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Abpro Holdings, INC.?

Key financial highlights from Abpro Holdings, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for ABPWW?

The investment thesis for ABPWW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Abpro Holdings, INC.?

Key executives identified across Abpro Holdings, INC.'s filings include Miles Suk, Jonathan H. Talcott, E. Peter Strand, Michael K. Bradshaw, Jr., Ian Chan and 3 others.

What are the main risk factors for Abpro Holdings, INC. stock?

Of ABPWW's 48 assessed filings, 11 were flagged high-risk, 13 medium-risk, and 24 low-risk.

What are recent predictions and forward guidance from Abpro Holdings, INC.?

Forward guidance and predictions for Abpro Holdings, INC. are extracted from SEC filings as they are enriched.

View on Read The Filing